Suchergebnisse - "Lervat, Cyril"

PubPharm (42)

1

Consensus survey on the management of children with chemotherapy-induced febrile neutropenia and at low risk of severe infection

enthalten in: Pediatric hematology and oncology | 2024

von Givone, A. | Duval-Destin, J. | Delebarre, M. | +3

2

Uncommon metachronous multiple sites recurrences of metastatic osteosarcoma cured by surgery : a case report

enthalten in: Acta oncologica (Stockholm, Sweden) | 2023

von Moisan, R. | Leroy, X. | Fron, D. | +2

3

Nationwide Study of Continuous Deep Sedation Practices Among Pediatric Palliative Care Teams

enthalten in: Journal of pain and symptom management | 2023

von Ridley, A. | Vial-Cholley, E. | Robert, G. | +6

4

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France

enthalten in: International journal of cancer | 2023

von Corvest, V. | Marec-Bérard, P. | Lervat, C. | +25

5

Management and outcomes of adolescent and young adult sarcoma patients : results from the French nationwide database NETSARC

enthalten in: BMC cancer | 2023

von Kubicek, P. | Cesne, A. | Lervat, C. | +47

6

Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC

enthalten in: BMC cancer | 2023

von Kubicek, P. | Cesne, A. | Lervat, C. | +47

7

Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer : a pilot study

enthalten in: BMJ supportive & palliative care | 2022

von Courade, M. | Bertrand, A. | Guerrini-Rousseau, L. | +10

8

Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis

enthalten in: Cancer research | 2022

von Marchais, A. | Marques da Costa, M. | Job, B. | +21

9

Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050) : a multicentre, open-label, multicohort, phase 1/2 study

enthalten in: The Lancet. Oncology | 2021

von Gaspar, N. | Venkatramani, R. | Hecker-Nolting, S. | +19

CommentIn: Lancet Oncol. 2021 Sep;22(9):1206-1207. - PMID 34416160

10

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial : What Can We Learn for Further Phase-II Trials?

enthalten in: Cancers | 2021

von Thebault, E. | Piperno-Neumann, S. | Tran, D. | +17

1
2
3
4
5
Nächster »
[5]